A randomised controlled study of trivalent inactivated influenza vaccine conducted in HIV-infected adults with CD4+ T cell counts >200 μg/ml in South Africa reported 75% (95% CI 9.2-95.6) efficacy in adults [38]. The gene discussed is CD4; the disease is influenza.